(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

Le Dai,Fen-Er Chen,Min-Qin Chen

DOI: https://doi.org/10.1107/s1600536807015991

2007-01-01

Abstract:The title compound, C13H15NO3, contains a chiral cisdisubstituted oxazine linked to a phenyl ring at the C-2 atom. The racemic crystal structure is stabilized by both intra- and intermolecular C-H center dot center dot center dot O hydrogen bonds.

What problem does this paper attempt to address?

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

chao wu,yanjun guo,xiaolong zhang,aibao xia

DOI: https://doi.org/10.1080/15421406.2014.928446

IF: 0.7

2015-01-01

Molecular Crystals and Liquid Crystals

Abstract:The title compound, (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one, was synthesized and characterized by H-1 and C-13 NMR and HRMS spectroscopy. Its absolute molecular configuration was investigated by X-ray crystallography. The crystal structure analysis revealed that the structure exhibits intermolecular hydrogen bonds of the type O-H horizontal ellipsis O. The methyl group and chlorophenyl group are located in the cis configuration. The conformation is stabilized by weak intermolecular C-H... O interactions.
(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

Long Zhao,Chao Wu,Wen-Zeng Weng,Chu-Xia Yan,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536812013098

2012-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:The crystal structure of the title compoud, C17H20BrNO3, contains three chiral centers, which all exhibit an S configuration. The C=C double bond has an E conformation. The cyclohexane ring is in a chair conformation. In the crystal, molecules are linked by weak N—O⋯Br interactions [O⋯Br = 3.136 (4) Å].
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809044195

2009-01-01

Abstract:In the title compound, C(28)H(27)NO(2), the oxazinone ring adopts a twist-boat conformation and the cyclo-hexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical inter-molecular C-H⋯O hydrogen bonds.
(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

Chao Wu,Yan-Jun Guo,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536813008659

2013-01-01

Abstract:The title compound, C14H14BrNO4, contains a tricyclic ring system including three contiguous stereocenters all of which exhibit an R configuration. The cyclo-hexa-none ring adopts a chair conformation. The central oxane ring assumes a strained envelope conformation, with five of the ring atoms being nearly coplanar with the bromo-phenyl group and with the C atom adjacent to the O atom and fused with the cyclo-hexa-none ring as the flap. In the crystal, mol-ecules are linked into a three-dimensional network by C-H⋯O inter-actions.
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1H-2,3-benzoxazin-4-one

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536809044195

2009-01-01

Abstract:In the title compound, C28H27NO2, the oxazinone ring adopts a twist-boat conformation and the cyclohexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical intermolecular C—H...O hydrogen bonds.
rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

Ning Ye,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536812005946

2012-01-01

Abstract:In the title compound, C(31)H(29)ClN(2)O(3), the two heterocyclic rings, belonging to a system of five condensed rings, adopt conformations intermediate between twist-boat and sofa. The secondary amide group is involved in a weak intramolecular N-H⋯N hydrogen bond. In the crystal, molecules are linked by pairs of C-H⋯Cl hydrogen bonds to form inversion dimers. These dimers are linked via a C-H⋯O interaction to form chains propagating along the b-axis direction.
rac-7-[(2E)-But-2-enoyl]-13-chloro-N-cyclohexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide

Ning Ye,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536812005946

2012-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:In the title compound, C31H29ClN2O3, the two heterocyclic rings, belonging to a system of five condensed rings, adopt conformations intermediate between twist-boat and sofa. The secondary amide group is involved in a weak intramolecular N—H...N hydrogen bond. In the crystal, molecules are linked by pairs of C—H...Cl hydrogen bonds to form inversion dimers. These dimers are linked via a C—H...O interaction to form chains propagating along the b-axis direction.
Rac-7-[(2e)-but-2-enoyl]-13-chloro-n-cyclohexyl-7,8-dihydro-5h-isochromeno[4,3-c]phenanthridine-8-carboxamide

Ning Ye

DOI: https://doi.org/10.1107/s1600536812005946

2012-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:In the title compound, C31H29ClN2O3, the two heterocyclic rings, belonging to a system of five condensed rings, adopt conformations intermediate between twist-boat and sofa. The secondary amide group is involved in a weak intramolecular N—H⋯N hydrogen bond. In the crystal, molecules are linked by pairs of C—H⋯Cl hydrogen bonds to form inversion dimers. These dimers are linked via a C—H⋯O interaction to form chains propagating along the b-axis direction.
(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Benguo Lin,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536813002560

2013-01-01

Abstract:In the title compound, C(28)H(33)NO(4)·CH(2)Cl(2), the pyrrolidone ring adopts a twisted envelope conformation and the cyclo-hexene has a half-chair conformation. In the crystal, weak C-H⋯O hydrogen bonds link the components into chains along [100].
N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

Jia-Lu Luo,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809028712

2009-01-01

Abstract:In the title compound, C(29)H(27)N(3)O(5), a dibenz[b,f][1,4]oxazepine derivative, the cyclo-hexane ring adopts a chair conformation, the oxazepine seven-membered ring has a twist-boat conformation, and the piperidin-2-one ring assumes a flattened boat conformation. Inter-molecular N-H⋯O hydrogen bonding between imino and nitro groups links two mol-ecules into a centrosymmetric dimer.
N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

Huo Ming Li,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810014996

2010-01-01

Abstract:The title compound, C(21)H(17)BrN(2)O(4), a 2-phenoxy-2-phenyl-acetamide derivative, exhibits a stereogenic center but crystallizes as a racemate as indicated by the centrosymmetric space group. In the molecular structure, the nitro-substituted benzene ring is coplanar [dihedral angle = 12.9 (1)degrees] with the plane formed by H-N-C(=O)-C=O due to intramolecular N-H center dot center dot center dot O hydrogen-bond interactions.
4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

N Xue,YZ Hu

DOI: https://doi.org/10.1107/s1600536805042005

2005-01-01

Abstract:The structure of the title compound, C30H33N3O10, consists of an almost planar imidazolin-2-one system connecting two planar substituted phenyl groups and a roughly planar 3,4,5-trimethoxyanilinocarbonyl fragment which forms a dihedral angle of 95.17 (9)degrees with the heterocyclic ring.
(R,S)-Methyl 3-methyl-5-oxo-1-phenylcyclo-hex-3-ene-1-carboxylate

Li Ying Yao,Chen Zhang,Bisong Wang

DOI: https://doi.org/10.1107/S1600536806021441

2006-01-01

Abstract:The title compound, C15H16O3, has two molecules in the asymmetric unit. The cyclohex-2-enone ring has an envelope conformation in both molecules. The crystal exhibits twinning. The molecular packing in the crystal structure is determined by weak intermolecular C - H⋯O interactions. © 2006 International Union of Crystallography. All rights reserved.
Ethyl 4-(4-Chloro-phen-yl)-2-methyl-5-oxo-5,6,7,8-tetra-hydro-quinoline-3-carboxyl-ate.

Ke Wang,Weike Wang,Yifeng Wang,Danqian Xu

DOI: https://doi.org/10.1107/s1600536813016541

2013-01-01

Abstract:In the title compound, C19H18ClNO3, the non-aromatic part of the fused ring system adopts an envelope conformation with the central methyl-ene C atom as the flap. The dihedral angle between the pyridine and benzene rings is 56.98 (3)°. In the crystal, mol-ecules are linked into double layers parallel to (100) by a network of weak C-H⋯O inter-actions.
Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

Xing-Yao Li,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536812008136

2012-01-01

Abstract:In the title compound, C(13)H(13)NO(4), the fused-ring system is nearly planar, with an r.m.s. deviation of 0.0408 Å. In the crystal, mol-ecules are linked into centrosymmetric dimers by a pair of N-H⋯O hydrogen bonds. The ethyl group is disordered over two positions in a ratio of 0.758 (6):0.242 (6).
6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

JX Xu,S Jin,ZY Zhang,TCW Mak

DOI: https://doi.org/10.1107/s0108270198005630

1998-01-01

Acta Crystallographica Section C Crystal Structure Communications

Abstract:The title compound, C31H24ClNO2S, has a cis-ring-fusion tricyclic structure, which is formed from a benzene ring, a seven-membered heterocyclic thiazepine ring and a 1,3-oxazinone ring. The 1,5-thiazepine ring has a slightly distorted boat-like conformation, whereas the 1,3-oxazinone ring adopts a half-chair conformation.
(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Jian Zhao,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017010

2010-01-01

Abstract:The title compound, C(28)H(26)N(2)O(4), crystallizes as a racemate with four stereogenic centers. In the molecule, the pyrrolidone ring adopts an envelope conformation and the cyclohexene ring has a twisted envelope conformation. In the crystal structure, molecules are linked by weak intermolecular C-H center dot center dot center dot O hydrogen bonds.
Methyl (2S)-2-[(5r)-3,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-4-yl]-3-phenylprop Anoate

JX Xu,XY Li,ZM Wang,QC Yang,CH Yan

DOI: https://doi.org/10.1107/s0108270198015492

1999-01-01

Abstract:In the title compound, C24H22N2O3, the 4,5-dihydro-1,2,4-oxadiazole ring system is in an envelope conformation with the C1, N1, C8 and N2 sets of atoms in a common plane with O1 0.110(3)Angstrom out of this plane. The chiral C atom in the five-membered ring, C1, is in the R configuration, which was identified by referring to the known configuration of the atom C15 in the (S)-phenylalanine moiety.
2-(2-Chloro-phen-yl)-N-cyclo-hexyl-2-oxoacetamide.

Xiu-Dan Jin,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536813005904

2013-01-01

Abstract:In the title compound, C14H16ClNO2, the cyclo-hexyl ring has a chair conformation. The dihedral angle between the benzene ring and the mean plane of the four planar C atoms of the cyclo-hexyl ring is 45.2 (3)°. The two carbonyl groups are trans to one another, with an O=C-C=O torsion angle of -137.1 (3)°. In the crystal, mol-ecules are linked by N-H⋯O hydrogen bonds forming chains propagating along [001]. A region of disordered electron density, situated near the unit-cell corners, was treated using the SQUEEZE routine in PLATON [Spek (2009 ▶). Acta Cryst. D65, 148-155]. It gave a solvent-accessible void of ca 400 Å(3) for only 21 electrons. It is probably due to traces of the solvent of crystallization and was not taken into account during structure refinement.
Ethyl (4aR*,7S*,8S*,8aS*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1H-isochromene-8-carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810017009

2010-01-01

Abstract:In the title compound, C18H20O4, both the tetrahydropyranone ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C—H⋯O hydrogen bonding.

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

Rac-7-[(2e)-but-2-enoyl]-13-chloro-n-cyclohexyl-7,8-dihydro-5h-isochromeno[4,3-c]phenanthridine-8-carboxamide

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

(R,S)-Methyl 3-methyl-5-oxo-1-phenylcyclo-hex-3-ene-1-carboxylate

Ethyl 4-(4-Chloro-phen-yl)-2-methyl-5-oxo-5,6,7,8-tetra-hydro-quinoline-3-carboxyl-ate.

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Methyl (2S)-2-[(5r)-3,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-4-yl]-3-phenylprop Anoate

2-(2-Chloro-phen-yl)-N-cyclo-hexyl-2-oxoacetamide.

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(1<i>S</i>*,4a<i>R</i>*,5<i>S</i>*,6<i>S</i>*,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

Rac-7-[(2e)-but-2-enoyl]-13-chloro-n-cyclohexyl-7,8-dihydro-5h-isochromeno[4,3-c]phenanthridine-8-carboxamide

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

(R,S)-Methyl 3-methyl-5-oxo-1-phenylcyclo-hex-3-ene-1-carboxylate

Ethyl 4-(4-Chloro-phen-yl)-2-methyl-5-oxo-5,6,7,8-tetra-hydro-quinoline-3-carboxyl-ate.

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Methyl (2S)-2-[(5r)-3,5-diphenyl-4,5-dihydro-1,2,4-oxadiazol-4-yl]-3-phenylprop Anoate

2-(2-Chloro-phen-yl)-N-cyclo-hexyl-2-oxoacetamide.

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate